The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 04, 2025

Filed:

Aug. 17, 2021
Applicants:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

The Wistar Institute of Anatomy and Biology, Philadelphia, PA (US);

Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);

Inventors:

David B. Weiner, Merion, PA (US);

Ami Patel, Philadelphia, PA (US);

Jian Yan, Wallingford, PA (US);

Assignees:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

The Wistar Institute of Anatomy and Biology, Plymouth Meeting, PA (US);

Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 9/00 (2006.01); A61K 39/12 (2006.01); A61K 39/39 (2006.01); A61P 31/12 (2006.01); C07K 14/54 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 9/0009 (2013.01); A61K 39/12 (2013.01); A61K 39/39 (2013.01); A61P 31/12 (2018.01); C07K 14/54 (2013.01); C07K 14/5434 (2013.01); C07K 14/5443 (2013.01); A61K 38/00 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55527 (2013.01); A61K 2039/55538 (2013.01); A61K 2039/58 (2013.01); A61K 2039/70 (2013.01); C07K 2319/02 (2013.01); C12N 2760/14122 (2013.01); C12N 2760/14134 (2013.01);
Abstract

Nucleic acid molecules and compositions comprising one or more nucleic acid sequences that encode a consensusglycoproteinimmunogens are disclosed. The coding sequences optionally include operable linked coding sequence that encode a signal peptide. Immunomodulatory methods and methods of inducing an immune response againstare disclosed. Method of preventingand methods of treating individuals infected withare disclosed. Consensusproteins are disclosed.


Find Patent Forward Citations

Loading…